Doctor profile · Federal record

Dr. Jeffrey Yorio, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Student in an Organized Health Care Education/Training Program · Austin, TX

  • NPI 1215197314
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 18 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
6204 Balcones Dr
Austin, TX 787314214
(512) 427-9400
fax (512) 342-2723
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
June 2008 — 18 yrs on file
Profile last updated
November 15, 2017
Year of graduation
2008 — 18 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Texas #N5499
Medicaid (3)
TX #282281902 · TX #282281901 · TX #282281903

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1215197314. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
96,325
Distinct HCPCS
10
Medicare allowed
$1,430,010
HCPCS Description Services Patients Avg allowed
J1453 Injection, fosaprepitant, 1 mg 14,550 46 $0
J9271 Injection, pembrolizumab, 1 mg 13,200 27 $54
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 12,390 16 $3
J9267 Injection, paclitaxel, 1 mg 10,891 25 $0
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 10,200 91 $0
J1756 Injection, iron sucrose, 1 mg 9,800 23 $0
J0185 Injection, aprepitant, 1 mg 4,290 17 $2
J0897 Injection, denosumab, 1 mg 2,100 14 $22
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,040 88 $0
Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg 1,930 14 $27

In context: peer comparison

Among 8 peers in Austin Hematology & Oncology Physician, average services per provider: 1,180. This provider delivers 82× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,121
Transactions
16
Manufacturers
13
Payer (manufacturer) Industry Txns Amount
Array Biopharma INC 1 $630.00
Exelixis INC. 1 $136.78
Incyte Corporation 1 $84.99
Genzyme Corporation 1 $46.50
Regeneron Healthcare Solutions, INC. 2 $44.78
AstraZeneca Pharmaceuticals Lp 1 $29.35
Janssen Biotech, INC. 2 $28.67
Daiichi Sankyo INC. 1 $27.69
Iovance Biotherapeutics, INC. 1 $22.68
Janssen Pharmaceuticals, INC 1 $22.00
Pfizer INC. 2 $19.86
Celgene Corporation 1 $14.05
Gilead Sciences, INC. 1 $13.47

By nature of payment

Compensation for Services Other Than Consulting, Including Serving As Faculty or As A Speaker at A Venue Other Than A Continuing Education Program
$630
Food and Beverage
$364
Education
$127

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,137
Patients
296
Total drug cost
$770,141
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 131 25 $1,650
Prednisone Generic 127 43 $780
Eliquis (Apixaban) Brand 122 29 $111,452
Potassium Chloride Generic 117 29 $4,227
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 104 37 $3,052
Gabapentin Generic 79 25 $843
Ondansetron Odt (Ondansetron) Brand 76 39 $874
Xarelto (Rivaroxaban) Brand 68 18 $89,356
Acyclovir Generic 66 12 $3,740
Dexamethasone Generic 61 28 $682

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Jeffrey Yorio's medical specialty?
Dr. Jeffrey Yorio practices Hematology & Oncology Physician in Austin, TX.
Where does Dr. Jeffrey Yorio practice?
Dr. Jeffrey Yorio practices at 6204 Balcones Dr, Austin, TX 787314214. Office phone: 5124279400.
What is Dr. Jeffrey Yorio's NPI?
Dr. Jeffrey Yorio's National Provider Identifier (NPI) is 1215197314, issued by NPPES.
Does Dr. Jeffrey Yorio accept Medicare assignment?
Yes. Dr. Jeffrey Yorio accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jeffrey Yorio commonly perform?
Top Medicare-reported procedures in 2023: Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881). Source: CMS Medicare Physician & Other Practitioners file.